Acasti Pharma | ACST - Ebit

Aktienkurs
4.60
Täglich Wechseln
0.11 2.45%
Monatlich
3.60%
Jährlich
113.95%
Q2 Prognose
3.51




Ebit Veränderung Datum
Acasti Pharma USD -3.7M 1.13M 2024-12
Addus HomeCare USD 42.28M 9.34M 2025-12
Amarin USD -2.26M 564K 2025-12
Cassava Sciences USD -13.55M 1.69M 2025-12
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Option Care Health USD 91.5M 6.99M 2025-12
Organigram Holdings CAD -20.13M 7.92M 2025-12
Tilray USD -20.01M 9.34M 2025-09